0001140361-11-029089.txt : 20110520 0001140361-11-029089.hdr.sgml : 20110520 20110520162516 ACCESSION NUMBER: 0001140361-11-029089 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20110519 FILED AS OF DATE: 20110520 DATE AS OF CHANGE: 20110520 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SIGA TECHNOLOGIES INC CENTRAL INDEX KEY: 0001010086 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133864870 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 35 EAST 62ND STREET CITY: NEW YORK STATE: NY ZIP: 10065 BUSINESS PHONE: 212-672-9100 MAIL ADDRESS: STREET 1: 35 EAST 62ND STREET CITY: NEW YORK STATE: NY ZIP: 10065 FORMER COMPANY: FORMER CONFORMED NAME: SIGA PHARMACEUTICALS INC DATE OF NAME CHANGE: 19961108 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ROSE ERIC A MD CENTRAL INDEX KEY: 0001139301 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-23047 FILM NUMBER: 11861907 MAIL ADDRESS: STREET 1: 161 FORT WASHINGTON AVENUE STREET 2: 7TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10032 4 1 doc1.xml FORM 4 X0303 4 2011-05-19 0 0001010086 SIGA TECHNOLOGIES INC SIGA 0001139301 ROSE ERIC A MD C/O SIGA TECHNOLOGIES, INC. 35 EAST 62ND STREET NEW YORK NY 10065 1 1 0 0 Chief Executive Officer Common Stock, par value $.0001 per share 2011-05-19 4 S 0 41500 13.65 D 562180 D Common Stock, par value $.0001 per share 13300 I By Spouse The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.54 to $13.81, inclusive. The reporting person undertakes to provide to SIGA Technologies, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. The proceeds from sales reported on this Form 4 are anticipated to be used to pay the taxes that have accrued in connection with the recent equity grants made to Dr. Rose under the Issuer's 2010 Stock Incentive Plan. /s/ Eric A. Rose 2011-05-20